News
JP Morgan Maintains Overweight on Day One Biopharmaceutical, Raises Price Target to $36
22 Apr 24
News, Price Target, Analyst Ratings
Piper Sandler Maintains Overweight on Day One Biopharmaceutical, Maintains $40 Price Target
26 Mar 24
News, Price Target, Analyst Ratings
Piper Sandler Maintains Overweight on Day One Biopharmaceutical, Lowers Price Target to $40
28 Feb 24
News, Price Target, Analyst Ratings
Goldman Sachs Maintains Buy on Day One Biopharmaceutical, Lowers Price Target to $44
27 Feb 24
News, Price Target, Analyst Ratings
Oppenheimer Reiterates Perform on Day One Biopharmaceuticalto Perform
27 Feb 24
News, Reiteration, Analyst Ratings
Day One Cash, Cash Equivalents And Short-Term Investments Totaled $366.3M On December 31, 2023 Providing Runway Into 2026
26 Feb 24
Earnings, News